NASDAQ:BPTH
Bio-Path Holdings Stock News
$2.61
-0.0500 (-1.88%)
At Close: May 03, 2024
Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
10:00am, Tuesday, 08'th Nov 2022 Benzinga
Gainers
Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 66.5% to settle at $29.10 on Monday amid recent reports suggesting Donald Trump could announce a 2024 presidential run this week.
Bio-Path Holdings to Announce Third Quarter 2022 Financial Results on November 15, 2022
07:00am, Tuesday, 08'th Nov 2022
HOUSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a po
Bio-Path Holdings Announces First Patient Dosed in Phase 1/1b Study of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients
11:00am, Monday, 24'th Oct 2022 GlobeNewswire Inc.
BP1002 Offers Unique Opportunity for Venetoclax-Resistant Patients by Utilizing RNAi to Limit Cell’s Ability to Produce Bcl-2 Protein BP1002 Offers Unique Opportunity for Venetoclax-Resistant Patien
Bio-Path Holdings to Present at H.C. Wainwright 24th Annual Global Investment Conference
11:00am, Tuesday, 06'th Sep 2022 GlobeNewswire Inc.
HOUSTON, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a
Bio-Path Holdings to Present at H.C. Wainwright 24th Annual Global Investment Conference
07:00am, Tuesday, 06'th Sep 2022
HOUSTON, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a p
Bio-Path Holdings Inc.'s (BPTH) CEO Peter Nielsen on Q2 2022 Results - Earnings Call Transcript
11:34am, Tuesday, 16'th Aug 2022
Bio-Path Holdings, Inc. (NASDAQ:BPTH ) Q2 2022 Earnings Conference Call August 16, 2022 8:30 AM ET Company Participants Will O'Connor - Stern Investor Relations Peter Nielsen - CEO and CFO Anthony Pri
Bio-Path Holdings to Announce Second Quarter 2022 Financial Results on August 16, 2022
11:00am, Tuesday, 09'th Aug 2022 GlobeNewswire Inc.
HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a
Bio-Path Holdings to Announce Second Quarter 2022 Financial Results on August 16, 2022
07:00am, Tuesday, 09'th Aug 2022
HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a po
10 Biggest Price Target Changes For Thursday
12:26pm, Thursday, 19'th May 2022 Benzinga
Telsey Advisory Group cut the price target for Bath & Body Works, Inc. (NYSE: BBWI) from $70 to $60. Bath & Body Works shares fell 6.9% to $40.00 in pre-market trading.
Piper Sandler cut the price t
Bio Path Holdings Inc. (BPTH) CEO Peter Nielsen on Q1 2022 Results - Earnings Call Transcript
10:43am, Tuesday, 17'th May 2022
Bio Path Holdings Inc. (NASDAQ:BPTH ) Q1 2022 Results Conference Call May 17, 2022 8:30 AM ET Company Participants Peter Nielsen - President, CEO Anthony Price - SVP, Finance, Accounting & Administrat
Bio-Path Holdings to Announce First Quarter 2022 Financial Results on May 17, 2022
07:00am, Tuesday, 10'th May 2022
HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a por
Bio-Path Holdings Presents BP1003 Data at 2022 American Association for Cancer Research Annual Meeting
08:01pm, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
Preclinical Data Support BP1003 Combination Therapy to Treat Breast and Ovarian Cancers Preclinical Data Support BP1003 Combination Therapy to Treat Breast and Ovarian Cancers
Why Bio-Path Holdings Shares Are Rising After Hours
04:57pm, Tuesday, 12'th Apr 2022
Bio-Path Holdings Inc (NASDAQ: BPTH) shares are trading higher in Tuesday's after-hours session following the company's BP1003 data presentation at the 2022 American Association for Cancer Research
Bio-Path Holdings, Inc. (BPTH) Q4 2021 Earnings Call Transcript
07:59am, Saturday, 12'th Mar 2022 AlphaStreet
Bio-Path Holdings, Inc. (NASDAQ: BPTH) Q4 2021 earnings call dated Mar. 11, 2022 Corporate Participants: Will O’Connor — Investor Relations Peter Nielsen — President, Chief Executive Officer and Chief Financial Officer Anthony Price — Senior Vice […] The post Bio-Path Holdings, Inc. (BPTH) Q4 2021 Earnings Call Transcript first appeared on AlphaStreet .
